bioAffinity Technologies’ CyPath Lung, noninvasive lung cancer diagnostic receives Canadian patent
bioAffinity Technologies, Inc., a biotechnology company advancing early-stage cancer diagnostics, announced its patent related to a method to detect lung disease through flow cytometry analysis of sputum has been allowed by the Canadian Patent Office. This …